About Galaxy Diagnostics
Galaxy Diagnostics is a company based in Durham (United States) founded in 2009.. Galaxy Diagnostics has raised $6.72 million across 7 funding rounds from investors including HHS. Galaxy Diagnostics offers products and services including Bartonella Digital ePCR and Lyme Borrelia Direct Detect Nanotrap. Galaxy Diagnostics operates in a competitive market with competitors including Inflammatix, Karius, MeMed, Visby Medical and NeuMoDx, among others.
- Headquarter Durham, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Galaxy Diagnostics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$6.72 M (USD)
in 7 rounds
-
Latest Funding Round
$4.14 M (USD), Series A
Apr 09, 2025
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Galaxy Diagnostics
Galaxy Diagnostics offers a comprehensive portfolio of products and services, including Bartonella Digital ePCR and Lyme Borrelia Direct Detect Nanotrap. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Detects Bartonella infections in blood samples using advanced PCR technology.
Identifies Lyme disease antigens in urine for accurate infection confirmation.
Unlock access to complete
Funding Insights of Galaxy Diagnostics
Galaxy Diagnostics has successfully raised a total of $6.72M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $4.14 million completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series A — $4.1M
-
First Round
First Round
(22 Apr 2009)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2025 | Amount | Series A - Galaxy Diagnostics | Valuation |
investors |
|
| Aug, 2023 | Amount | Series A - Galaxy Diagnostics | Valuation |
investors |
|
| Sep, 2018 | Amount | Grant - Galaxy Diagnostics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Galaxy Diagnostics
Galaxy Diagnostics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Galaxy Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Galaxy Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Galaxy Diagnostics Comparisons
Competitors of Galaxy Diagnostics
Galaxy Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, Karius, MeMed, Visby Medical and NeuMoDx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of diagnostic solutions for systemic infections
|
|
| domain | founded_year | HQ Location |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| domain | founded_year | HQ Location |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| domain | founded_year | HQ Location |
Portable PCR diagnostics for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of a platform for low cost molecular testing
|
|
| domain | founded_year | HQ Location |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Galaxy Diagnostics
Frequently Asked Questions about Galaxy Diagnostics
When was Galaxy Diagnostics founded?
Galaxy Diagnostics was founded in 2009.
Where is Galaxy Diagnostics located?
Galaxy Diagnostics is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Is Galaxy Diagnostics a funded company?
Galaxy Diagnostics is a funded company, having raised a total of $6.72M across 7 funding rounds to date. The company's 1st funding round was a Grant of $224.88K, raised on Apr 22, 2009.
What does Galaxy Diagnostics do?
Galaxy Diagnostics is an infectious disease testing company founded by researchers at NC State University College of Veterinary Medicine. The company offers PCR tests to confirm Bartonella infection and other pathogens. Its product, the Bartonella ePCR test combines proprietary enrichment culture with compassionate PCR methods to provide a highly sensitive detection test for Bartonella spp. The company offers PCR tests to detect a broad range of species within each genus of Bartonella spp, Anaplasma spp, Ehrlichia spp, Rickettsia spp, and Babesia.
Who are the top competitors of Galaxy Diagnostics?
Galaxy Diagnostics's top competitors include Visby Medical, Inflammatix and MeMed.
What products or services does Galaxy Diagnostics offer?
Galaxy Diagnostics offers Bartonella Digital ePCR and Lyme Borrelia Direct Detect Nanotrap.
Who are Galaxy Diagnostics's investors?
Galaxy Diagnostics has 1 investor. Key investors include HHS.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.